Volume 3, Issue 1 (5-2020)                   2020, 3(1): 0-0 | Back to browse issues page

Ethics code: IR.MEDILAM.REC.1393.112

XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Mendeley  
Zotero  
RefWorks

Azizi M, shohani B, Bakhtiyari S, Asadolahi K, rezaee S. Investigation the start time to complete Form of Oscar Gloyal to determine appropriate time of therapy involvement in gerbils with damage in spinal cord. Journal title 2020; 3 (1)
URL: http://newresearch.medilam.ac.ir/article-1-1068-en.html
Department of Anatomical Sciences, School of Medicine, Ilam University of Medical sciences, Ilam, Iran
Abstract:   (2158 Views)
Objective: spinal cord injury (SCI)is one of the most serious clinical diseases
that not only affects the patient physically and psychologically,but also its effects
influence on family andsociety.In SCI ,glial cells that their most abundant
areastrocytes,convert in to the reactive astrocytes which are the main components
of glial scars. In glial scar, the extracellular matrix increases, that mainly secreted
by reactive astrocytes.Amongthecomponents, ChondroitinSulfate proteoglycans
play an important role ininhibiting of axonal regeneration.
After SCI, dermatansulfate and chondroitin sulfateincrease.For treating the
impotence (disability) caused by SCI,there is used cell therapy to greatly limitthe
formation of glial scar and to provide thegrowth of axons, but in these
studies,improvement is limited due to the lack of knowledge about the right time
for the rapeutic intervention. Therefore, the aim of this study is todetermine the
start time for formation of glial scar in contusion model of spinal cord injury to
achieve effective timeof therapeutic intervention for reducing inhibitory effect of
glial scar as the most basic physical barrier to axonal regeneration.
 
     
: Cross sectional | Subject: General
Received: 2020/06/8 | Accepted: 2020/06/15 | Published: 2020/05/30

Add your comments about this proposal : Your username or Email:
CAPTCHA

Send email to the proposal executer


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.